Post Operative Nausea And Vomiting – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Post Operative Nausea And Vomiting – Drugs In Development, 2024 report and make more profitable business decisions.
Post Operative Nausea and Vomiting is one of the most common problems observed after chemo, anesthesia, and surgical interventions. Triggering of CTZ, vagal mucosal pathway, Neuronal pathways etc. when stimulated activates the sensation of vomiting. Nausea is defined as an unpleasant sensation while nausea is a forceful expulsion of even a small amount of upper gastrointestinal contents. Surgical factors, patient factors, medications, and intra and post operative factors result in PONV. Anti-emetics are primary chosen therapeutic strategy for treating nausea and vomiting. Parenteral nutrition to prevent dehydration. Ondansetron, Prochlorperazine, anti-cholinergic, dopamine antagonists are chosen.
The Post Operative Nausea And Vomiting drugs in development market research report provide comprehensive information on the therapeutics under development for Post Operative Nausea And Vomiting, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Post Operative Nausea And Vomiting and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Post Operative Nausea And Vomiting | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 12 molecules, with 11 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Post Operative Nausea And Vomiting therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Post Operative Nausea And Vomiting pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Post Operative Nausea And Vomiting treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Amzell BVArovella Therapeutics Ltd
Cellix Bio Pvt Ltd
Eagle Pharmaceuticals Inc
Luxena Pharmaceuticals Inc
Myungmoon Pharm Co Ltd
Nanjing Entai Pharmaceutical Technology Co Ltd
Nanjing Zenkom Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
Zhejiang Academy of Medical Sciences
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Post Operative Nausea And Vomiting reports